Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JAGSON PHAR vs PLETHICO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JAGSON PHAR PLETHICO PHARMA JAGSON PHAR/
PLETHICO PHARMA
 
P/E (TTM) x 37.7 -0.1 - View Chart
P/BV x 6.2 0.0 36,707.0% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 JAGSON PHAR   PLETHICO PHARMA
EQUITY SHARE DATA
    JAGSON PHAR
Mar-23
PLETHICO PHARMA
Mar-14
JAGSON PHAR/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs420254 165.4%   
Low Rs25431 812.8%   
Sales per share (Unadj.) Rs90.3604.6 14.9%  
Earnings per share (Unadj.) Rs10.232.5 31.4%  
Cash flow per share (Unadj.) Rs10.751.3 20.8%  
Dividends per share (Unadj.) Rs5.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs57.3473.7 12.1%  
Shares outstanding (eoy) m26.2034.07 76.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.70.2 1,581.6%   
Avg P/E ratio x33.14.4 752.9%  
P/CF ratio (eoy) x31.62.8 1,138.5%  
Price / Book Value ratio x5.90.3 1,954.0%  
Dividend payout %49.00-   
Avg Mkt Cap Rs m8,8314,859 181.8%   
No. of employees `000NANA-   
Total wages/salary Rs m6521,547 42.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,36720,598 11.5%  
Other income Rs m57419 13.7%   
Total revenues Rs m2,42421,017 11.5%   
Gross profit Rs m3072,938 10.4%  
Depreciation Rs m12642 1.9%   
Interest Rs m41,747 0.2%   
Profit before tax Rs m348968 35.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m81-138 -58.4%   
Profit after tax Rs m2671,107 24.1%  
Gross profit margin %13.014.3 90.9%  
Effective tax rate %23.2-14.3 -162.6%   
Net profit margin %11.35.4 210.1%  
BALANCE SHEET DATA
Current assets Rs m1,72218,877 9.1%   
Current liabilities Rs m35211,896 3.0%   
Net working cap to sales %57.933.9 170.8%  
Current ratio x4.91.6 308.4%  
Inventory Days Days978 12.1%  
Debtors Days Days32198 16.3%  
Net fixed assets Rs m30414,269 2.1%   
Share capital Rs m131341 38.5%   
"Free" reserves Rs m1,37015,798 8.7%   
Net worth Rs m1,50116,139 9.3%   
Long term debt Rs m04,706 0.0%   
Total assets Rs m2,02633,146 6.1%  
Interest coverage x85.31.6 5,486.1%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.20.6 188.0%   
Return on assets %13.48.6 155.6%  
Return on equity %17.86.9 259.5%  
Return on capital %23.513.0 180.1%  
Exports to sales %2.321.4 10.9%   
Imports to sales %015.2 0.0%   
Exports (fob) Rs m554,402 1.3%   
Imports (cif) Rs mNA3,136 0.0%   
Fx inflow Rs m554,402 1.3%   
Fx outflow Rs m413,184 1.3%   
Net fx Rs m141,219 1.2%   
CASH FLOW
From Operations Rs m4672,437 19.1%  
From Investments Rs m-577-6,265 9.2%  
From Financial Activity Rs m-52,490 -0.2%  
Net Cashflow Rs m-11524 -468.7%  

Share Holding

Indian Promoters % 24.8 57.8 42.9%  
Foreign collaborators % 43.3 0.0 -  
Indian inst/Mut Fund % 1.6 19.4 8.1%  
FIIs % 0.7 2.7 27.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.9 42.3 75.5%  
Shareholders   16,282 16,430 99.1%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JAGSON PHAR With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on JAGSON PHAR vs PLETHICO PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

JAGSON PHAR vs PLETHICO PHARMA Share Price Performance

Period JAGSON PHAR PLETHICO PHARMA S&P BSE HEALTHCARE
1-Day 1.10% -4.91% 0.34%
1-Month 23.05% -1.24% 0.25%
1-Year 1.97% -70.21% 54.31%
3-Year CAGR 53.26% -66.86% 15.04%
5-Year CAGR 69.46% -51.20% 19.87%

* Compound Annual Growth Rate

Here are more details on the JAGSON PHAR share price and the PLETHICO PHARMA share price.

Moving on to shareholding structures...

The promoters of JAGSON PHAR hold a 68.1% stake in the company. In case of PLETHICO PHARMA the stake stands at 57.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of JAGSON PHAR and the shareholding pattern of PLETHICO PHARMA.

Finally, a word on dividends...

In the most recent financial year, JAGSON PHAR paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 49.0%.

PLETHICO PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of JAGSON PHAR, and the dividend history of PLETHICO PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 941 Points | Bank Nifty Hits Record High | 5 Reasons Why Indian Share Market is Rising Sensex Today Rallies 941 Points | Bank Nifty Hits Record High | 5 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.